Biomerica: Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval
Biomerica's Fortel PSA test gains UAE approval for prostate cancer detection. Q2 shows 5% sales growth and reduced losses through cost optimization. read more
Read full article »
CEO
Zackary Irani
Biomerica is a California-based biomedical company that develops and manufactures diagnostic and therapeutic products for gastrointestinal and inflammatory diseases.
Read more